Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-04-007097
Filing Date
2004-03-09
Accepted
2004-03-09 14:39:26
Documents
7
Period of Report
2003-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2130496z10-k.htm 10-K 574438
3 EX-14 a2130496zex-14.htm EX-14 7599
4 EX-23 a2130496zex-23.htm EX-23 2018
5 EX-31.1 a2130496zex-31_1.htm EX-31.1 5260
6 EX-31.2 a2130496zex-31_2.htm EX-31.2 5223
7 EX-32.1 a2130496zex-32_1.htm EX-32.1 2461
8 EX-32.2 a2130496zex-32_2.htm EX-32.2 2451
  Complete submission text file 0001047469-04-007097.txt   601588
Mailing Address 410 W HARRISON ST SEATTLE WA 98119
Business Address 410 W HARRISON ST SEATTLE WA 98119 206-286-25
NEORX CORP (Filer) CIK: 0000755806 (see all company filings)

EIN.: 911261311 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-16614 | Film No.: 04657015
SIC: 2835 In Vitro & In Vivo Diagnostic Substances